Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum.
Fusobacterium necrophorum subspecies funduliforme is an obligate anaerobic Gram-negative rod causing invasive infections such as the life-threatening Lemierre's syndrome (sore throat, septicemia, jugular vein thrombosis, and disseminated infection). The aim of our study was to understand if and how F. necrophorum avoids C activation. We studied 12 F. necrophorum subsp. funduliforme strains isolated from patients with sepsis. All strains were resistant to serum killing after a 1-h incubation in 20% serum. The bacteria bound, at different levels, the C inhibitor factor H (fH). Binding was ionic and specific in nature and occurred via sites on both the N terminus and the C terminus of fH. Bound fH remained functionally active as a cofactor for factor I in the cleavage of C3b. Interestingly, patients with the most severe symptoms carried strains with the strongest ability to bind fH. An increased C3b deposition and membrane attack complex formation on the surface of a weakly fH-binding strain was observed and its survival in serum at 3.5 h was impaired. This strain had not caused a typical Lemierre's syndrome. These data, and the fact that fH-binding correlated with the severity of disease, suggest that the binding of fH contributes to virulence and survival of F. necrophorum subsp. funduliforme in the human host. Our data show, for the first time, that an anaerobic bacterium is able to bind the C inhibitor fH to evade C attack.
Friberg
Nathalie
N
Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland
Carlson
Petteri
P
Kentala
Erna
E
Mattila
Petri S
PS
Kuusela
Pentti
P
Meri
Seppo
S
Jarva
Hanna
H
D000693:Anaerobiosis / Q000276:immunology; D001422:Bacterial Adhesion / Q000276:immunology*; D001770:Blood Bactericidal Activity / Q000276:immunology*; D003179:Complement C3b / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology; D017242:Complement Factor H / Q000378:metabolism / Q000502:physiology; D003170:Complement Pathway, Alternative / Q000276:immunology*; D017077:Culture Media, Conditioned; D004306:Dose-Response Relationship, Immunologic; D005675:Fusobacterium necrophorum / Q000254:growth & development* / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D011485:Protein Binding / Q000276:immunology; D013211:Staphylococcus aureus / Q000254:growth & development / Q000276:immunology / Q000472:pathogenicity; D013296:Streptococcus pneumoniae / Q000254:growth & development / Q000276:immunology / Q000472:pathogenicity
C493495:CFH protein, human; D017077:Culture Media, Conditioned; D003179:Complement C3b; D017242:Complement Factor H